| Net income | |
| Depreciation and amortization | 384.7M |
| Deferred income taxes | -57M |
| Provision for loan loss | 651M |
| Non-cash stock compensation | 59.5M |
| Fair value (gain) loss on interest-rate derivatives | |
| Amortization of discount on convertible senior notes | |
| Change in trade accounts receivable | |
| Change in other assets | |
| Change in accounts payable and accrued expenses | |
| Change in deferred revenue | -114.1M |
| Change in other liabilities | |
| Excess tax benefits from stock-based compensation | |
| Other | 106.7M |
| Net cash provided by operating activities | |
| Change in redemption settlement assets | 55.4M |
| Payments for acquired businesses, net of cash | 0 |
| Change in restricted cash | -126.8M |
| Change in credit card receivables | -1.05B |
| Purchase of credit card receivables | |
| Change in cash collateral, restricted | 2.3M |
| Capital expenditures | -158.3M |
| Investments in the stock of investees | |
| Other | -2.9M |
| Net cash (used in) provided by investing activities | |
| Borrowings under debt agreements | 3.09B |
| Repayments of borrowings | -2.31B |
| Issuances of certificates of deposit | |
| Repayments of certificates of deposit | |
| Borrowings from asset-backed securities | 2.57B |
| Repayments/maturities of asset-backed securities | -3.15B |
| Payment of capital lease obligations | |
| Payment of deferred financing costs | -20.7M |
| Excess tax benefits from stock-based compensation | |
| Proceeds from issuance of common stock | |
| Purchase of treasury shares | -692.8M |
| Net cash used in financing activities | |
| Effect of exchange rate changes on cash and cash equivalents | |
| Change in cash and cash equivalents | 332.5M |
| Cash effect on adoption of ASC 860 and ASC 810 | |
| Cash and cash equivalent at beginning of period | 1.17B |
| Cash and cash equivalents at end of period | 1.5B |
| Interest paid | 287.2M |
| Income taxes paid, net | 342.7M |